LifePoint Hospitals Inc. (NASDAQ:LPNT) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Wednesday.
According to Zacks, “LifePoint Hospitals, Inc. is engaged in the operation of general, acute care hospitals in non-urban communities. The company’s general, acute care hospitals usually provide the range of medical and surgical services commonly available in hospitals in non-urban markets. These hospitals also provide diagnostic and emergency services, as well as outpatient and ancillary services including outpatient surgery, laboratory, radiology, respiratory therapy and physical therapy. “
Several other equities research analysts have also weighed in on the company. Mizuho lowered their price objective on LifePoint Hospitals from $61.50 to $56.00 and set a “neutral” rating on the stock in a research note on Monday, August 1st. Credit Suisse Group AG restated a “buy” rating and set a $64.00 price target on shares of LifePoint Hospitals in a research report on Tuesday, August 30th. RBC Capital Markets restated an “outperform” rating and set a $77.00 price target (down from $84.00) on shares of LifePoint Hospitals in a research report on Monday, August 1st. Citigroup Inc. restated a “buy” rating and set a $68.00 price target on shares of LifePoint Hospitals in a research report on Friday, September 30th. Finally, TheStreet lowered LifePoint Hospitals from a “buy” rating to a “hold” rating in a research report on Thursday, August 25th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and eight have assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $72.06.
LifePoint Hospitals (NASDAQ:LPNT) traded up 1.61% during mid-day trading on Wednesday, hitting $59.43. The stock had a trading volume of 785,201 shares. The firm has a market cap of $2.54 billion, a P/E ratio of 19.79 and a beta of 0.89. LifePoint Hospitals has a 1-year low of $54.82 and a 1-year high of $76.39. The stock has a 50 day moving average of $57.52 and a 200-day moving average of $64.07.
LifePoint Hospitals (NASDAQ:LPNT) last released its quarterly earnings data on Friday, July 29th. The company reported $0.71 earnings per share for the quarter, missing the consensus estimate of $0.90 by $0.19. LifePoint Hospitals had a net margin of 2.08% and a return on equity of 7.14%. The company earned $1.59 billion during the quarter, compared to the consensus estimate of $1.61 billion. During the same quarter in the prior year, the company posted $1.00 earnings per share. The company’s revenue for the quarter was up 25.3% on a year-over-year basis. Analysts predict that LifePoint Hospitals will post $3.51 EPS for the current fiscal year.
A number of hedge funds have recently modified their holdings of LPNT. Fuller & Thaler Asset Management Inc. acquired a new stake in shares of LifePoint Hospitals during the second quarter valued at approximately $111,000. Acrospire Investment Management LLC acquired a new stake in shares of LifePoint Hospitals during the first quarter valued at approximately $125,000. Pacad Investment Ltd. acquired a new stake in shares of LifePoint Hospitals during the second quarter valued at approximately $141,000. US Bancorp DE boosted its position in LifePoint Hospitals by 1.6% in the second quarter. US Bancorp DE now owns 2,316 shares of the company’s stock worth $152,000 after buying an additional 37 shares during the period. Finally, Bank of Montreal Can purchased a new position in LifePoint Hospitals during the second quarter worth about $168,000. 97.10% of the stock is currently owned by institutional investors and hedge funds.
LifePoint Hospitals Company Profile
LifePoint Health, Inc, formerly LifePoint Hospitals, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. The Company operates through healthcare services segment. The Company operates over 70 hospital campuses in over 20 states, having a total of over 8,240 licensed beds.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for LifePoint Hospitals Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Hospitals Inc. and related companies with MarketBeat.com's FREE daily email newsletter.